Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses

Thread starter International: Top News And Analysis
Start date Jul 9, 2025

International: Top News And Analysis

Guest

Jul 9, 2025

Novo Nordisk will lose its patent protection on its branded semaglutide drugs Ozempic and Wegovy in Canada after not paying a maintenance fee in 2019.

Continue reading...

You must log in or register to reply here.

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Thread Information

Title: Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses

Prefix: N/A

Forum: World News

Start date: Jul 9, 2025

Last reply date: Jul 9, 2025

Replies: 0

Thread Tags

Thread statistics

Created: International: Top News And Analysis, Jul 9, 2025

Replies: 0

Views: 14

About Us

XenTR Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

Color picker

Search